OncotypeDX

Learn more about Genomic Health's diagnostic tests for breast, colon and prostate cancer, which can help patients and their doctor make better, more informed treatment decisions.

Until Every Woman Knows...

Oncotype DX for DCIS

DCIS / Stage 0 breast cancer affects 1 out of every 5 women diagnosed with breast cancer in the U.S. Not all DCIS patients will benefit from the addition of radiation therapy to their treatment. Learn more about the Oncotype DX test for DCIS.

Oncotype DX - 10 Years & Beyond

Over the past decade, we have redefined personalized medicine through the innovation of Oncotype DX, making genomics an indispensable part of breast, colon and prostate cancer diagnosis and treatmentLearn more about our next decade and how we are continuing to use genomic information to make cancer care smarter.

Press Releases

April 22, 2014   

Global Adoption of Oncotype DX® Breast Cancer Test Continues to Grow with Achievement of Two Significant Intern...

March 19, 2014   

Genomic Health Announces Presentation of New Data Further Supporting Use of Oncotype DX® in Europe

All press releases